• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Technology a central factor among interrelated challenges

Article

The most significant pressures facing payers evolve constantly, though they rarely change radically from year to year. While payers strive to lower administrative costs and improve efficiencies, manage healthcare costs and grow the business, recent years have seen substantial change in how they address these issues.

THE MOST SIGNIFICANT pressures facing payers evolve constantly, though they rarely change radically from year to year. While payers strive to lower administrative costs and improve efficiencies, manage healthcare costs and grow the business, recent years have seen substantial change in how they address these issues.






Managing administrative costs and improving operational efficiencies are constant issues for all health plans, and leading payers on the path to high performance approach the issue in multiple ways, including:

HEALTHCARE COSTS AND CARE MANAGEMENT

Cost inflation owes its continued existence to the cost and use of pharmaceuticals, increasing numbers of medical interventions for all types of care, regulations and benefits mandates and widespread variations in medical practice, among other issues. Additionally, new technology, such as implantable cardiac defibrillators and other types of implants, is expensive, as are genomic testing and specialty pharmacy treatments for common conditions such as rheumatoid arthritis and cancer-not to mention rare but expensive conditions such as Gaucher disease. To manage these growing costs, leading payers are instituting:

GROWTH CHALLENGES

Revenue growth will be increasingly difficult, as the commercial insurable market shrinks and costs shift away from premiums. But leading payers are focusing aggressively on intelligent growth, making carefully calibrated strategic decisions based on their capabilities and goals in:

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.